These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17487782)

  • 1. BioVision 2007, Immunization for all. 11-14 March 2007, Lyon, France.
    Voisin E
    IDrugs; 2007 May; 10(5):317-9. PubMed ID: 17487782
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress report on the National Immunization Strategy.
    Kondro W
    CMAJ; 2007 Jun; 176(13):1811-3. PubMed ID: 17576972
    [No Abstract]   [Full Text] [Related]  

  • 3. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
    Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
    Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations from the Strategic Advisory Group of Experts to the Department of Immunization, Vaccines and Biologicals.
    Wkly Epidemiol Rec; 2005 Jan; 80(2):11-8. PubMed ID: 15685865
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy analysis: an essential research tool for the introduction of vaccines in developing countries.
    Mahoney R
    J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing the immunization coverage paradox: A matter of children's rights and social justice.
    Durrheim DN; Cashman P
    Clin Ther; 2010 Aug; 32(8):1496-8. PubMed ID: 20728762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunizing the world.
    Gates B; Gates M
    Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines and global health.
    Greenwood B; Salisbury D; Hill AV
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2733-42. PubMed ID: 21893534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
    Molina-Aguilera IB
    Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
    [No Abstract]   [Full Text] [Related]  

  • 12. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of strategic management with vaccination in the terms of globalization.
    Rabrenovic M; Cukanovic Karavidic M; Stosic I
    Int J Qual Health Care; 2018 Apr; 30(3):234-239. PubMed ID: 29447353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination lags behind in middle-income countries.
    Berkley S
    Nature; 2019 May; 569(7756):309. PubMed ID: 31089234
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives.
    Dellepiane N; Wood D
    Vaccine; 2015 Jan; 33(1):52-61. PubMed ID: 24300593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.
    Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF
    J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.